CLASCOTERONE

CLASCOTERONE was reported 1419 times

These side effects are most commonly reported by patients taking CLASCOTERONE:

# Side effect Count
0 PRODUCT STORAGE ERROR 333
1 PRODUCT PHYSICAL CONSISTENCY ISSUE 329
2 PRODUCT USE COMPLAINT 286
3 PRODUCT DOSE OMISSION ISSUE 184
4 PRODUCT USE ISSUE 153
5 DRUG INEFFECTIVE 146
6 THERAPY CESSATION 86
7 POOR QUALITY PRODUCT ADMINISTERED 84
8 PRODUCT PHYSICAL ISSUE 78
9 CONDITION AGGRAVATED 76
10 PRODUCT QUALITY ISSUE 67
11 ACNE 46
12 OFF LABEL USE 38
13 ERYTHEMA 30
14 LIQUID PRODUCT PHYSICAL ISSUE 25
15 RASH 25
16 SKIN IRRITATION 23
17 EXPIRED PRODUCT ADMINISTERED 22
18 THERAPY INTERRUPTED 21
19 PRURITUS 19
20 SKIN BURNING SENSATION 19
21 FATIGUE 17
22 DRY SKIN 15
23 PAIN 13
24 SKIN EXFOLIATION 13
25 ACCIDENTAL EXPOSURE TO PRODUCT 11
26 AMENORRHOEA 11
27 ACNE CYSTIC 10
28 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 10
29 PRODUCT ADMINISTRATION INTERRUPTED 10
30 HYPERSENSITIVITY 8
31 INSOMNIA 8
32 NAUSEA 8
33 ANXIETY 7
34 DIZZINESS 7
35 HAIR GROWTH ABNORMAL 7
36 PRODUCT CONTAINER ISSUE 7
37 PRODUCT DISPENSING ERROR 7
38 DRUG HYPERSENSITIVITY 6
39 DYSPNOEA 6
40 HEADACHE 6
41 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 6
42 MALAISE 6
43 PRODUCT TEMPERATURE EXCURSION ISSUE 6
44 SCRATCH 6
45 APPLICATION SITE REACTION 5
46 DISEASE RECURRENCE 5
47 PRODUCT ADMINISTRATION ERROR 5
48 PRODUCT DEPOSIT 5
49 SEBORRHOEA 5
50 SEIZURE 5
51 SIMPLE PARTIAL SEIZURES 5
52 SKIN DISCOLOURATION 5
53 SURGERY 5
54 THERAPEUTIC RESPONSE DECREASED 5
55 URTICARIA 5
56 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 5
57 ALOPECIA 4
58 APPLICATION SITE ACNE 4
59 DEPRESSION 4
60 DISEASE PROGRESSION 4
61 HYPOTHALAMIC PITUITARY ADRENAL AXIS SUPPRESSION 4
62 INTERMENSTRUAL BLEEDING 4
63 MALABSORPTION FROM APPLICATION SITE 4
64 PRODUCT PACKAGING ISSUE 4
65 PRODUCT PRESCRIBING ERROR 4
66 PRODUCT SUBSTITUTION ISSUE 4
67 SKIN DISORDER 4
68 SKIN STRIAE 4
69 SWELLING FACE 4
70 THERAPEUTIC RESPONSE UNEXPECTED 4
71 APPLICATION SITE DRYNESS 3
72 APPLICATION SITE PAIN 3
73 ARTHRALGIA 3
74 ASTHENIA 3
75 BURNING SENSATION 3
76 CHEMICAL BURN 3
77 COUGH 3
78 DECREASED APPETITE 3
79 DERMATITIS 3
80 DERMATITIS ATOPIC 3
81 EMOTIONAL DISTRESS 3
82 EXPOSURE DURING PREGNANCY 3
83 EYE IRRITATION 3
84 FACIAL PAIN 3
85 INCORRECT DOSE ADMINISTERED 3
86 INFLAMMATION 3
87 MENSTRUATION DELAYED 3
88 MENSTRUATION IRREGULAR 3
89 MIGRAINE 3
90 NASOPHARYNGITIS 3
91 PRODUCT APPEARANCE CONFUSION 3
92 PRODUCT CONTAMINATION PHYSICAL 3
93 PRODUCT DISPENSING ISSUE 3
94 PRODUCT LEAKAGE 3
95 PUSTULE 3
96 PYREXIA 3
97 RASH PRURITIC 3
98 SCAR 3
99 SKIN EROSION 3
100 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 3
101 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3
102 VOMITING 3
103 WEIGHT DECREASED 3
104 ABNORMAL DREAMS 2
105 ACNE PUSTULAR 2
106 ANGIOEDEMA 2
107 APPLICATION SITE DISCOMFORT 2
108 APPLICATION SITE EXFOLIATION 2
109 ATRIAL FIBRILLATION 2
110 BLISTER 2
111 BLOOD PRESSURE INCREASED 2
112 CONSTIPATION 2
113 COVID-19 2
114 CYST 2
115 DIARRHOEA 2
116 DRUG ERUPTION 2
117 DRUG INTERACTION 2
118 DRY EYE 2
119 DYSGEUSIA 2
120 DYSPHAGIA 2
121 DYSURIA 2
122 GASTRITIS 2
123 GYNAECOMASTIA 2
124 HAEMORRHAGE 2
125 HEART RATE INCREASED 2
126 HEAVY MENSTRUAL BLEEDING 2
127 HORMONE LEVEL ABNORMAL 2
128 INABILITY TO AFFORD MEDICATION 2
129 INFLUENZA 2
130 INITIAL INSOMNIA 2
131 INJECTION SITE SWELLING 2
132 INTENTIONAL DOSE OMISSION 2
133 INTENTIONAL PRODUCT MISUSE 2
134 LETHARGY 2
135 MENSTRUAL DISORDER 2
136 MICTURITION URGENCY 2
137 MIDDLE INSOMNIA 2
138 MUSCLE SPASMS 2
139 MYALGIA 2
140 NIGHTMARE 2
141 PAIN IN EXTREMITY 2
142 PELVIC FLOOR DYSFUNCTION 2
143 PERIPHERAL SWELLING 2
144 PNEUMONIA 2
145 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 2
146 PRODUCT ADHESION ISSUE 2
147 PRODUCT AVAILABILITY ISSUE 2
148 PRODUCT DOSE OMISSION IN ERROR 2
149 PRODUCT FORMULATION ISSUE 2
150 PRODUCT ODOUR ABNORMAL 2
151 PRODUCT PRESCRIBING ISSUE 2
152 PRODUCT SOLUBILITY ABNORMAL 2
153 PRODUCTIVE COUGH 2
154 PURGING 2
155 RESPIRATORY DISORDER 2
156 RHEUMATOID ARTHRITIS 2
157 SINUSITIS 2
158 SKIN ATROPHY 2
159 SKIN LACERATION 2
160 SKIN REACTION 2
161 SKIN WOUND 2
162 SLEEP APNOEA SYNDROME 2
163 SOMNOLENCE 2
164 STRESS 2
165 SUICIDAL IDEATION 2
166 SUPRAVENTRICULAR EXTRASYSTOLES 2
167 TENDERNESS 2
168 TERMINAL INSOMNIA 2
169 THERAPEUTIC PRODUCT EFFECT DECREASED 2
170 TREATMENT NONCOMPLIANCE 2
171 URINARY INCONTINENCE 2
172 VENTRICULAR EXTRASYSTOLES 2
173 VISION BLURRED 2
174 VISUAL IMPAIRMENT 2
175 WEIGHT INCREASED 2
176 YELLOW SKIN 2
177 ABDOMINAL DISTENSION 1
178 ABDOMINAL PAIN 1
179 ABDOMINAL PAIN UPPER 1
180 ABSCESS 1
181 ADMINISTRATION SITE REACTION 1
182 ADRENAL INSUFFICIENCY 1
183 ADRENAL SUPPRESSION 1
184 ADVERSE DRUG REACTION 1
185 ANDROGENETIC ALOPECIA 1
186 APPENDICITIS 1
187 APPLICATION SITE IRRITATION 1
188 APPLICATION SITE PAPULES 1
189 ARTHRITIS BACTERIAL 1
190 ATROPHY 1
191 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1
192 AUTONOMIC NEUROPATHY 1
193 BACK PAIN 1
194 BALANCE DISORDER 1
195 BLOOD PRESSURE DECREASED 1
196 BLOOD TESTOSTERONE DECREASED 1
197 BLOOD THYROID STIMULATING HORMONE INCREASED 1
198 BREAST CANCER 1
199 BREAST PAIN 1
200 BREAST SWELLING 1
201 BREAST TENDERNESS 1
202 CHEST DISCOMFORT 1
203 CHEST PAIN 1
204 CHLOASMA 1
205 CHRONIC SINUSITIS 1
206 CORNEAL ABRASION 1
207 COUNTERFEIT PRODUCT ADMINISTERED 1
208 CROHN^S DISEASE 1
209 DERMAL ABSORPTION IMPAIRED 1
210 DERMATITIS ALLERGIC 1
211 DERMATITIS EXFOLIATIVE GENERALISED 1
212 DERMATOMYOSITIS 1
213 DEVELOPMENTAL REGRESSION 1
214 DISCHARGE 1
215 DISCOMFORT 1
216 DISCONTINUED PRODUCT ADMINISTERED 1
217 DISTURBANCE IN ATTENTION 1
218 DRUG TOLERANCE INCREASED 1
219 DRY MOUTH 1
220 DYSSTASIA 1
221 ECZEMA 1
222 EOSINOPHIL COUNT DECREASED 1
223 EXTRA DOSE ADMINISTERED 1
224 EYE PAIN 1
225 EYE SWELLING 1
226 EYELID SCAR 1
227 FACE OEDEMA 1
228 FALL 1
229 FEEDING DISORDER 1
230 FEELING ABNORMAL 1
231 FEELING JITTERY 1
232 FOLLICULITIS 1
233 FOOT OPERATION 1
234 FORDYCE SPOTS 1
235 FOREIGN BODY SENSATION IN EYES 1
236 FUNGAL INFECTION 1
237 GASTROINTESTINAL DISORDER 1
238 HEART RATE DECREASED 1
239 HEART RATE IRREGULAR 1
240 HIDRADENITIS 1
241 HORDEOLUM 1
242 HYPERHIDROSIS 1
243 HYPERMOBILITY SYNDROME 1
244 HYPERTENSION 1
245 HYPERTRICHOSIS 1
246 HYPOTRICHOSIS 1
247 ILLNESS 1
248 INCORRECT PRODUCT ADMINISTRATION DURATION 1
249 INCREASED APPETITE 1
250 INFECTION 1
251 INFLUENZA LIKE ILLNESS 1
252 INFUSION RELATED REACTION 1
253 INJECTION SITE MASS 1
254 INJECTION SITE PAIN 1
255 INJECTION SITE RASH 1
256 INTENTIONAL UNDERDOSE 1
257 INTRACRANIAL PRESSURE INCREASED 1
258 INTRAOCULAR PRESSURE INCREASED 1
259 IRON DEFICIENCY 1
260 IRRITABILITY 1
261 JUVENILE IDIOPATHIC ARTHRITIS 1
262 LIBIDO DECREASED 1
263 LOSS OF CONSCIOUSNESS 1
264 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1
265 LOWER RESPIRATORY TRACT INFECTION 1
266 LUPUS-LIKE SYNDROME 1
267 LYMPHADENOPATHY 1
268 MEDICATION ERROR 1
269 MEIBOMIAN GLAND DYSFUNCTION 1
270 MENOPAUSE 1
271 MENTAL DISORDER 1
272 MOOD ALTERED 1
273 MUSCLE TIGHTNESS 1
274 MUSCLE TWITCHING 1
275 MUSCULAR WEAKNESS 1
276 OCULAR HYPERAEMIA 1
277 OEDEMA PERIPHERAL 1
278 OPHTHALMIC MIGRAINE 1
279 ORAL ALLERGY SYNDROME 1
280 OROPHARYNGEAL PAIN 1
281 OSTEOPOROSIS 1
282 PAINFUL RESPIRATION 1
283 PALPITATIONS 1
284 PANCREATITIS ACUTE 1
285 PAPULE 1
286 PARALYSIS 1
287 PARTIAL SEIZURES 1
288 PELVIC PAIN 1
289 PERIORAL DERMATITIS 1
290 PERIPHERAL VENOUS DISEASE 1
291 PHARYNGEAL SWELLING 1
292 PHOTOSENSITIVITY REACTION 1
293 POLYDIPSIA 1
294 POOR QUALITY SLEEP 1
295 POST INFLAMMATORY PIGMENTATION CHANGE 1
296 POST PROCEDURAL INFECTION 1
297 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 1
298 PRESCRIPTION FORM TAMPERING 1
299 PROCEDURAL NAUSEA 1
300 PRODUCT COMMUNICATION ISSUE 1
301 PRODUCT COMPLAINT 1
302 PRODUCT CONTAMINATION MICROBIAL 1
303 PRODUCT DISTRIBUTION ISSUE 1
304 PRODUCT EXPIRATION DATE ISSUE 1
305 PRODUCT LOT NUMBER ISSUE 1
306 PRODUCT OUTER PACKAGING ISSUE 1
307 PRODUCT PACKAGING QUANTITY ISSUE 1
308 PRODUCT PROCESS CONTROL ISSUE 1
309 PRODUCT RESIDUE PRESENT 1
310 PSEUDOFOLLICULITIS 1
311 PSORIASIS 1
312 QUALITY OF LIFE DECREASED 1
313 REBOUND ATOPIC DERMATITIS 1
314 REBOUND EFFECT 1
315 RENAL PAPILLARY NECROSIS 1
316 RESPIRATORY TRACT INFECTION 1
317 SEASONAL ALLERGY 1
318 SEDATION 1
319 SENSITIVE SKIN 1
320 SINUSITIS FUNGAL 1
321 SJOGREN^S SYNDROME 1
322 SKIN ABRASION 1
323 SKIN DISCOMFORT 1
324 SKIN FISSURES 1
325 SKIN HAEMORRHAGE 1
326 SKIN HYPERPIGMENTATION 1
327 SKIN INFECTION 1
328 SKIN INJURY 1
329 SKIN LESION 1
330 SKIN TEXTURE ABNORMAL 1
331 SLEEP DISORDER 1
332 SOMNAMBULISM 1
333 SPHINCTER OF ODDI DYSFUNCTION 1
334 STAPHYLOCOCCAL INFECTION 1
335 STEROID WITHDRAWAL SYNDROME 1
336 SUBCUTANEOUS ABSCESS 1
337 SUNBURN 1
338 SUSPECTED COUNTERFEIT PRODUCT 1
339 SUSPECTED PRODUCT QUALITY ISSUE 1
340 SWELLING 1
341 SWOLLEN TONGUE 1
342 SYSTEMIC LUPUS ERYTHEMATOSUS 1
343 THERAPY NON-RESPONDER 1
344 THROAT TIGHTNESS 1
345 THYROID DISORDER 1
346 THYROID HORMONES DECREASED 1
347 THYROID HORMONES INCREASED 1
348 TREATMENT DELAYED 1
349 TREATMENT FAILURE 1
350 TRIGGER FINGER 1
351 TRISOMY 21 1
352 UNEVALUABLE EVENT 1
353 UPPER RESPIRATORY TRACT INFECTION 1
354 URINARY TRACT INFECTION 1
355 VAGINAL HAEMORRHAGE 1
356 VITAMIN B COMPLEX DEFICIENCY 1
357 VULVAL DISORDER 1
358 VULVOVAGINAL DISCOMFORT 1
359 WITHDRAWAL SYNDROME 1
360 WRIST FRACTURE 1
361 WRONG PATIENT RECEIVED PRODUCT 1